Universal Health Services, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the three and nine months ended September 30, 2026, disclosing revenue growth, earnings results, and balance sheet changes across its hospital operations.

Key Highlights

  • Net revenues of $4.73 billion for the three months ended September 30, 2026, compared to $4.50 billion in the same period of 2025, according to the filing.
  • Net income attributable to UHS was $308,684 thousand for the third quarter of 2026, down from $372,957 thousand in the third quarter of 2025.
  • Nine-month net revenues reached $13,866,546 thousand for the period ended September 30, 2026, versus $12,878,781 thousand for the same period in 2025.
  • Diluted earnings per share attributable to UHS were $5.22 for the third quarter of 2026, compared to $5.86 in the prior-year quarter.
  • Total assets stood at $17,185,766 thousand as of September 30, 2026, up from $15,527,593 thousand at December 31, 2025.
  • Long-term debt increased to $5,627,528 thousand at September 30, 2026, from $4,004,393 thousand at December 31, 2025.
  • Shares outstanding as of October 31, 2026: Class A 6,574,600; Class B 50,403,612; Class C 661,688; Class D 12,217.

Universal Health Services Reports Third-Quarter and Year-to-Date 2026 Financial Results

Universal Health Services, Inc. (NYSE:UHS), a Delaware-incorporated holding company that operates acute care hospitals and behavioral health facilities through its subsidiaries including UHS of Delaware, Inc., reported net revenues of $4,733,352 thousand for the three months ended September 30, 2026. This compares to $4,495,245 thousand in the same quarter of 2025, according to the condensed consolidated statements of income included in the filing. Total operating charges for the quarter were $4,278,903 thousand, leaving income from operations of $454,449 thousand, down from $521,688 thousand in the prior-year quarter.

For the nine months ended September 30, 2026, the company reported net revenues of $13,866,546 thousand and income from operations of $1,473,984 thousand. Net income attributable to UHS for the nine-month period was $1,015,813 thousand, compared to $1,042,855 thousand in the nine months ended September 30, 2025. Diluted earnings per share attributable to UHS for the nine-month period were $16.86, versus $16.07 in the comparable prior-year period, the filing stated. Salaries, wages, and benefits represented the largest operating cost category, totaling $6,438,999 thousand for the nine-month period.

The balance sheet as of September 30, 2026 reflected goodwill of $4,736,949 thousand, up from $3,990,213 thousand at December 31, 2025, suggesting acquisition activity during the period. Accounts receivable, net, rose to $2,813,703 thousand from $2,602,434 thousand at year-end 2025. UHS common stockholders' equity was reported at $7,596,849 thousand, compared to $7,275,792 thousand at December 31, 2025. The company classified itself as a large accelerated filer in the filing.

What Was Disclosed

Universal Health Services filed its Form 10-Q for the quarter ended September 30, 2026, reporting quarterly net revenues of approximately $4.73 billion, diluted EPS of $5.22, total assets of approximately $17.19 billion, and a rise in long-term debt to approximately $5.63 billion compared to December 31, 2025.